Renaissance Technologies’s Vivani Medical VANI Stock Holding History

Renaissance Technologies’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.3K	Sell	37,295 -60,690	-62%	-$75.9K	﹤0.01%	3129
2025 Q4	$121K	Buy	97,985 +53,127	+118%	+$76.8K	﹤0.01%	2980
2025 Q3	$63.3K	Buy	+44,858	New	+$60.8K	﹤0.01%	3312
2024 Q2	–	Sell	-12,136	Closed	-$22K	–	3981
2024 Q1	$22K	Sell	12,136 -3,564	-23%	-$5.25K	﹤0.01%	3586
2023 Q4	$16K	Buy	+15,700	New	+$15.6K	﹤0.01%	3607
2023 Q1	–	Sell	-56,600	Closed	-$48K	–	4420
2022 Q4	$48K	Buy	+56,600	New	+$92.2K	﹤0.01%	3806
2022 Q2	–	Sell	-58,075	Closed	-$249K	–	4599
2022 Q1	$249K	Buy	+58,075	New	+$244K	﹤0.01%	3549
2021 Q1	–	Sell	-8,600	Closed	-$48K	–	3734
2020 Q4	$48K	Buy	+8,600	New	+$30.4K	﹤0.01%	3320

Other funds holding VANI

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TWM

Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies's VANI Position: Q1 2026 in Review

Renaissance Technologies reduced its Vivani Medical (VANI) stake by 62% in Q1 2026, selling an estimated $75.9K and leaving 37,295 shares worth $37.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

Renaissance Technologies first reported a position in VANI in Q4 2020 and has held it in 8 quarters since. The position peaked at $249K in Q1 2022. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.

Renaissance Technologies held 37,295 shares of Vivani Medical worth $37.3K as of Q1 2026.
Renaissance Technologies sold 60,690 Vivani Medical shares in Q1 2026, an estimated $75.9K.
Vivani Medical made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3129 holding.
Renaissance Technologies first reported a position in Vivani Medical in Q4 2020 and has held it in 8 quarters since.
Renaissance Technologies's Vivani Medical position peaked at $249K in Q1 2022.
43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.